Global Human Microbiome Market Research Report 2023(Status and Outlook)

Global Human Microbiome Market Research Report 2023(Status and Outlook)



Report Overview

The Human Microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

These microbes are generally not harmful to us, in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.

An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.

The Global Human Microbiome Market Size was estimated at USD 384.90 million in 2022 and is projected to reach USD 1521.89 million by 2029, exhibiting a CAGR of 21.70% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Human Microbiome market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Human Microbiome Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Human Microbiome market in any manner.

Global Human Microbiome Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Vedanta

Seres Therapeutics

Second Genome

Rebiotix

ActoGeniX

Enterome BioScience

AvidBiotics

4D Pharma Research Ltd

Enterologics

Metabogen

Metabiomics

Ritter Pharmaceuticals

Osel

Symberix

Miomics

Symbiotix Biotherapies

MicroBiome Therapeutics LLC

Market Segmentation (by Type)

Gastrointestinal Tract Human Micobiome

Urogenital Tract Human Micobiome

Others

Market Segmentation (by Application)

Artificial Joint

Cardiovascular Implant

Orthopedic

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Human Microbiome Market

Overview of the regional outlook of the Human Microbiome Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Human Microbiome
1.2 Key Market Segments
1.2.1 Human Microbiome Segment by Type
1.2.2 Human Microbiome Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Human Microbiome Market Overview
2.1 Global Market Overview
2.1.1 Global Human Microbiome Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Human Microbiome Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Human Microbiome Market Competitive Landscape
3.1 Global Human Microbiome Sales by Manufacturers (2018-2023)
3.2 Global Human Microbiome Revenue Market Share by Manufacturers (2018-2023)
3.3 Human Microbiome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Human Microbiome Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Human Microbiome Sales Sites, Area Served, Product Type
3.6 Human Microbiome Market Competitive Situation and Trends
3.6.1 Human Microbiome Market Concentration Rate
3.6.2 Global 5 and 10 Largest Human Microbiome Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Human Microbiome Industry Chain Analysis
4.1 Human Microbiome Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Human Microbiome Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Human Microbiome Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Human Microbiome Sales Market Share by Type (2018-2023)
6.3 Global Human Microbiome Market Size Market Share by Type (2018-2023)
6.4 Global Human Microbiome Price by Type (2018-2023)
7 Human Microbiome Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Human Microbiome Market Sales by Application (2018-2023)
7.3 Global Human Microbiome Market Size (M USD) by Application (2018-2023)
7.4 Global Human Microbiome Sales Growth Rate by Application (2018-2023)
8 Human Microbiome Market Segmentation by Region
8.1 Global Human Microbiome Sales by Region
8.1.1 Global Human Microbiome Sales by Region
8.1.2 Global Human Microbiome Sales Market Share by Region
8.2 North America
8.2.1 North America Human Microbiome Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Human Microbiome Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Human Microbiome Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Human Microbiome Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Human Microbiome Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Vedanta
9.1.1 Vedanta Human Microbiome Basic Information
9.1.2 Vedanta Human Microbiome Product Overview
9.1.3 Vedanta Human Microbiome Product Market Performance
9.1.4 Vedanta Business Overview
9.1.5 Vedanta Human Microbiome SWOT Analysis
9.1.6 Vedanta Recent Developments
9.2 Seres Therapeutics
9.2.1 Seres Therapeutics Human Microbiome Basic Information
9.2.2 Seres Therapeutics Human Microbiome Product Overview
9.2.3 Seres Therapeutics Human Microbiome Product Market Performance
9.2.4 Seres Therapeutics Business Overview
9.2.5 Seres Therapeutics Human Microbiome SWOT Analysis
9.2.6 Seres Therapeutics Recent Developments
9.3 Second Genome
9.3.1 Second Genome Human Microbiome Basic Information
9.3.2 Second Genome Human Microbiome Product Overview
9.3.3 Second Genome Human Microbiome Product Market Performance
9.3.4 Second Genome Business Overview
9.3.5 Second Genome Human Microbiome SWOT Analysis
9.3.6 Second Genome Recent Developments
9.4 Rebiotix
9.4.1 Rebiotix Human Microbiome Basic Information
9.4.2 Rebiotix Human Microbiome Product Overview
9.4.3 Rebiotix Human Microbiome Product Market Performance
9.4.4 Rebiotix Business Overview
9.4.5 Rebiotix Human Microbiome SWOT Analysis
9.4.6 Rebiotix Recent Developments
9.5 ActoGeniX
9.5.1 ActoGeniX Human Microbiome Basic Information
9.5.2 ActoGeniX Human Microbiome Product Overview
9.5.3 ActoGeniX Human Microbiome Product Market Performance
9.5.4 ActoGeniX Business Overview
9.5.5 ActoGeniX Human Microbiome SWOT Analysis
9.5.6 ActoGeniX Recent Developments
9.6 Enterome BioScience
9.6.1 Enterome BioScience Human Microbiome Basic Information
9.6.2 Enterome BioScience Human Microbiome Product Overview
9.6.3 Enterome BioScience Human Microbiome Product Market Performance
9.6.4 Enterome BioScience Business Overview
9.6.5 Enterome BioScience Recent Developments
9.7 AvidBiotics
9.7.1 AvidBiotics Human Microbiome Basic Information
9.7.2 AvidBiotics Human Microbiome Product Overview
9.7.3 AvidBiotics Human Microbiome Product Market Performance
9.7.4 AvidBiotics Business Overview
9.7.5 AvidBiotics Recent Developments
9.8 4D Pharma Research Ltd
9.8.1 4D Pharma Research Ltd Human Microbiome Basic Information
9.8.2 4D Pharma Research Ltd Human Microbiome Product Overview
9.8.3 4D Pharma Research Ltd Human Microbiome Product Market Performance
9.8.4 4D Pharma Research Ltd Business Overview
9.8.5 4D Pharma Research Ltd Recent Developments
9.9 Enterologics
9.9.1 Enterologics Human Microbiome Basic Information
9.9.2 Enterologics Human Microbiome Product Overview
9.9.3 Enterologics Human Microbiome Product Market Performance
9.9.4 Enterologics Business Overview
9.9.5 Enterologics Recent Developments
9.10 Metabogen
9.10.1 Metabogen Human Microbiome Basic Information
9.10.2 Metabogen Human Microbiome Product Overview
9.10.3 Metabogen Human Microbiome Product Market Performance
9.10.4 Metabogen Business Overview
9.10.5 Metabogen Recent Developments
9.11 Metabiomics
9.11.1 Metabiomics Human Microbiome Basic Information
9.11.2 Metabiomics Human Microbiome Product Overview
9.11.3 Metabiomics Human Microbiome Product Market Performance
9.11.4 Metabiomics Business Overview
9.11.5 Metabiomics Recent Developments
9.12 Ritter Pharmaceuticals
9.12.1 Ritter Pharmaceuticals Human Microbiome Basic Information
9.12.2 Ritter Pharmaceuticals Human Microbiome Product Overview
9.12.3 Ritter Pharmaceuticals Human Microbiome Product Market Performance
9.12.4 Ritter Pharmaceuticals Business Overview
9.12.5 Ritter Pharmaceuticals Recent Developments
9.13 Osel
9.13.1 Osel Human Microbiome Basic Information
9.13.2 Osel Human Microbiome Product Overview
9.13.3 Osel Human Microbiome Product Market Performance
9.13.4 Osel Business Overview
9.13.5 Osel Recent Developments
9.14 Symberix
9.14.1 Symberix Human Microbiome Basic Information
9.14.2 Symberix Human Microbiome Product Overview
9.14.3 Symberix Human Microbiome Product Market Performance
9.14.4 Symberix Business Overview
9.14.5 Symberix Recent Developments
9.15 Miomics
9.15.1 Miomics Human Microbiome Basic Information
9.15.2 Miomics Human Microbiome Product Overview
9.15.3 Miomics Human Microbiome Product Market Performance
9.15.4 Miomics Business Overview
9.15.5 Miomics Recent Developments
9.16 Symbiotix Biotherapies
9.16.1 Symbiotix Biotherapies Human Microbiome Basic Information
9.16.2 Symbiotix Biotherapies Human Microbiome Product Overview
9.16.3 Symbiotix Biotherapies Human Microbiome Product Market Performance
9.16.4 Symbiotix Biotherapies Business Overview
9.16.5 Symbiotix Biotherapies Recent Developments
9.17 MicroBiome Therapeutics LLC
9.17.1 MicroBiome Therapeutics LLC Human Microbiome Basic Information
9.17.2 MicroBiome Therapeutics LLC Human Microbiome Product Overview
9.17.3 MicroBiome Therapeutics LLC Human Microbiome Product Market Performance
9.17.4 MicroBiome Therapeutics LLC Business Overview
9.17.5 MicroBiome Therapeutics LLC Recent Developments
10 Human Microbiome Market Forecast by Region
10.1 Global Human Microbiome Market Size Forecast
10.2 Global Human Microbiome Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Human Microbiome Market Size Forecast by Country
10.2.3 Asia Pacific Human Microbiome Market Size Forecast by Region
10.2.4 South America Human Microbiome Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Human Microbiome by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Human Microbiome Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Human Microbiome by Type (2024-2029)
11.1.2 Global Human Microbiome Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Human Microbiome by Type (2024-2029)
11.2 Global Human Microbiome Market Forecast by Application (2024-2029)
11.2.1 Global Human Microbiome Sales (K Units) Forecast by Application
11.2.2 Global Human Microbiome Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings